Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Could this temperature sensor reduce power consumption in medical devices?
A new temperature sensor that runs at 113 pW could make wearables and even implantable medical devices less power dependent, according to research from the University of California at San Diego.
The temperature sensor, developed by electrical engineers at UCSD, uses about 628 times lower power than state-of-the-art power sources and is 10 billion times smaller than a watt. Considered “near zero power,” the engineers suggest that the temperature sensor could extend battery life in a variety of wearable or implantable devices that measure body temperature. It could able be used to create a new class of devices that is capable of harvesting its energy from the body or surrounding environments. Read more
4. AdvaMed protests FDA update to “intended use” language
AdvaMed last month sent a letter to the FDA criticizing a new rule which changes the group’s definition of “intended uses”, saying it could negatively impact scientific communication, device development and make manufacturer’s liable for any off-label use by merely knowing it exists.
The letter was released last week by the FDA, and is in response to a new rule, finalized in January but delayed for comment, which was originally intended to clarify rules about classifying tobacco products but which altered the definition of “intended uses.” Read more
3. Philips gains on strong Q2 results
Royal Philips shares are up today after the Dutch healthcare conglomerate said core second-quarter profits rose nearly 15% to $512.31 million (€439 million), just beating the consensus forecast.
The Amsterdam-based company, which spun off its lighting division last year to focus on medical devices and healthcare product, said sales grew 4% to $5.01 billion (€4.29 billion) on “strong” order intake. Read more
2. ‘Any moving vehicle’: Medtech seeks a path for medical device tax repeal as Trumpcare dies
The likely demise of Republican plans to repeal Obamacare and replace it with their own version of healthcare reform has the medtech industry casting about for another way to get a repeal of the medical device tax into law.
The U.S. House and Senate version of the Trumpcare legislation would have, among other things, done away with the 2.3% levy imposed on U.S. medical device sales by the Affordable Care Act in 2013. During the three years it was in effect (a two-year moratorium went into effect at the beginning of last year), the tax brought in $5.3 billion, well short of the $8.7 billion it was expected to bring in to IRS coffers. Repealing the tax is predicted to cut nearly $20 billion in revenues from the federal budget from 2018 to 2026. Read more
1. Proxy advisors back Stryker’s $700m Novadaq buy
A pair of investment advisory firms recommended that Novadaq Technologies shareholders vote to approve a pending, $700 million buyout bid from Stryker.
Mississauga, Ontario-based Novadaq said that proxy advisors Institutional Shareholder Services and Glass, Lewis & Co. backed the $11.75-per-share offer, which must win over at least 66⅔% of the quorum at a shareholders meeting slated for August 4. The offer is a 95.8% premium on NVDQ’s June 16 closing price, the day before the deal was announced. Read more
The post MassDevice.com +5 | The top 5 medtech stories for July 24, 2017 appeared first on MassDevice.
from MassDevice http://ift.tt/2uql8G4
Cap comentari:
Publica un comentari a l'entrada